Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on January 5, 2010. The report discloses the consolidated financial results for the fiscal year 2010 second quarter ended November 29, 2009. The filing incorporates a press release (Exhibit 99.1) by reference but explicitly states that the information is furnished and not "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The filing text provided does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the input text.
Material Changes
The filing does not provide specific details on material changes versus the prior comparable period. It serves solely as a notification that the results for the quarter ended November 29, 2009, have been announced via a press release.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information would be located in the referenced Exhibit 99.1 press release.
Investor Verification Checklist
- Verify the actual financial performance metrics (revenue, net income, EPS) by reviewing the attached Exhibit 99.1 Press Release.
- Confirm the discrepancy between the metadata company name ("LIFECORE BIOMEDICAL, INC.") and the registrant name in the filing ("LANDEC CORPORATION").
- Review the press release for any forward-looking statements or guidance regarding the fiscal year 2010 outlook.
- Check for any material changes in liquidity or capital resources detailed in the full press release.